Peptides Derived of Kunitz-Type Serine Protease Inhibitor as Potential Vaccine Against Experimental Schistosomiasis
Schistosomiasis is a significant public health problem in sub-Saharan Africa, China, Southeast Asia, and regions of South and Central America affecting about 189 million people. Kunitz-type serine protease inhibitors have been identified as important players in the interaction of other flatworm para...
Main Authors: | Juan Hernández-Goenaga, Julio López-Abán, Anna V. Protasio, Belén Vicente Santiago, Esther del Olmo, Magnolia Vanegas, Pedro Fernández-Soto, Manuel Alfonso Patarroyo, Antonio Muro |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-11-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.02498/full |
Similar Items
-
T Cell Peptides Derived from Invasive Stages of <i>Schistosoma mansoni</i> as Potential Schistosomiasis Vaccine
by: Julio López-Abán, et al.
Published: (2021-01-01) -
Kunitz-type protease inhibitor as a vaccine candidate against schistosomiasis mansoni
by: Shiwanthi L. Ranasinghe, et al.
Published: (2018-01-01) -
r-Sm14 - pRSETA efficacy in experimental animals
by: Celso Raul Romero Ramos, et al.
Published: (2001-09-01) -
Vaccination in murine schistosomiasis with adult worm derived antigens - II. Protective and immune response in inbred mice
by: Miriam Tendler, et al.
Published: (1992-01-01) -
Protective potential of antioxidant enzymes as vaccines for schistosomiasis in a non-human primate model
by: Claudia eCarvalho-Queiroz, et al.
Published: (2015-06-01)